Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tania Baresic"'
Autor:
Brigida Stanzione, Valentina Da Ros, Monica Schiappacassi, Elisa De Carlo, Giacomo Pelizzari, Tania Baresic, Roberto Doliana, Gustavo Baldassarre, Alessandra Bearz, Alessandro Del Conte
Publikováno v:
In Vivo
Background Osimertinib is a third-generation EGFR-tyrosine kinase inhibitor approved for the treatment of T790M-positive non-small-cell lung cancer. More recently, osimertinib demonstrated improved disease control compared to other EGFR-TKIs. Multipl
Autor:
Fabrizio Dal Moro, Laura Evangelista, Ilaria Ravelli, Franca Chierichetti, Tania Baresic, Tommaso Vincenzo Bartolotta, Pierpaolo Alongi, Eugenio Borsatti, Giuseppe Trifirò, Marco Rensi, I Rambaldi, Mirco Bartolomei, Manuel Tredici, Diego Cecchin, Fabio Zattoni, Elisabetta Brugola, Davide Donner, Orazio Schillaci, Agostino Chiaravalloti, Mohsen Farsad, Marta Burei, Decio Capobianco
Publikováno v:
Clinical nuclear medicine. 45(8)
Purpose The primary aim of this multicenter retrospective analysis is to examine the role of(18)F-choline PET/CT as a diagnostic tool for staging and restaging prostate cancer (PCa) in a large population in the light of 10 years of clinical experienc
Autor:
Giovanni Franchin, Carlo Gobitti, Alessandra Bearz, Alessandro Del Conte, Marco Trovo, Mauro G. Trovò, Emilio Minatel, Jerry Polesel, Imad Abu Rumeileh, Tania Baresic, Michele Avanzo, E. Durofil
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 88:1114-1119
Purpose To retrospectively assess toxicity and outcome of re-irradiation with stereotactic body radiation therapy (SBRT) in patients with recurrent or persistent non-small cell lung cancer (NSCLC), who were previously treated with radical radiation t
Autor:
Jerry Polesel, Giovanni Franchin, Paolo Fontana, A. Drigo, Marco Trovo, Tania Baresic, Mauro G. Trovò, Carlo Gobitti, Imad Abu Rumeileh, Alessandra Bearz, Emilio Minatel, Vittore Pagan
Publikováno v:
Lung Cancer. 83:78-82
Purpose We have previously shown the feasibility of delivering high doses of radiotherapy in malignant pleural mesothelioma (MPM) patients who underwent radical pleurectomy/decortication (P/D) or surgical biopsy. In this report, we present the long-t
Autor:
Tania Baresic, Carlo Gobitti, Giovanni Franchin, Marco Trovo, A. Drigo, Alessandro Del Conte, Emilio Minatel, Andrea Dassie, Alessandra Bearz, Jerry Polesel, Vittore Pagan, Mauro G. Trovò, Imad Abu Rumeileh
Publikováno v:
Journal of Thoracic Oncology. 7:1862-1866
Introduction: This study aimed to assess the safety of high doses of radiation delivered with tomotherapy to the intact lung after radical pleurectomy/decortication or biopsy for malignant pleural mesothelioma (MPM). Methods: Twenty-eight patients we
Autor:
Alessandra Viel, Giuseppe Corona, Gianmaria Miolo, Vincenzo Canzonieri, Davide Adriano Santeufemia, Tania Baresic, Angela Buonadonna, Della Puppa Lara
We report an interesting clinical case of a patient carrying a specific BRCA2 germline variant affected by bone and hepatic metastases from a high grade uterine stromal sarcoma who obtained a complete metabolic response after only 3 cycles of trabect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e22a846c81734d9ee09dbd8254666a
http://hdl.handle.net/11368/2968249
http://hdl.handle.net/11368/2968249
Autor:
Marco Trovo, A. Drigo, Vittore Pagan, Alessandra Bearz, Matteo Di Maso, Emilio Minatel, Gioia Bruschi, Carlo Furlan, Loredana Barresi, Alessandro Del Conte, Paolo Fontana, Tania Baresic, Giovanni Franchin
Publikováno v:
International journal of radiation oncology, biology, physics. 93(3)
Purpose To prospectively assess the survival, patterns of failure, and prognostic factors in a large cohort of patients with malignant pleural mesothelioma who had undergone a novel trimodal therapeutic approach, including lung-sparing surgery, chemo
Autor:
Manuela Bertola, Alessandro Del Conte, Fausto Tuccia, Tania Baresic, Salvatore Tumolo, Anna Bassini, Elvia Micheli, Giuseppina Gusso, Stefania Manente, Luisa Foltran, Silvana Saracchini, Sandro Sulfaro
Publikováno v:
Publons
641 Background: Trastuzumab combined to sequential chemotherapy with taxanes and anthracyclines as primary treatment achieved high rates of pathologic complete response (pCR) in HER2 positive BC. Liposome-encapsulated doxorubicin (DLNP) shown equal e